Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 2Delirium 2Thromboembolism 1Small Cell Lung Carcinoma 1Respiratory Insufficiency 1Postoperative Complications 1Pneumonia 1Pleural Effusion, Malignant 1Pleural Effusion 1Neurotoxicity Syndromes 1Neoplasms 1Myocardial Infarction 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Lung Diseases 1Inoperable Stage III Non-small Cell Lung Cancer 1Emergence Delirium 1Arrhythmias, Cardiac 1Angina, Unstable 1Agnosia 1Acute Coronary Syndrome 1

Interventions

Paclitaxel 2Amifostine 2Saline Solution 1Cisplatin 1Carboplatin 12,2'-dithiodiethanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Saline Solution × Thoracic × Clear all
NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Sun Yat-sen University

Phase 3 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡